secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0000950170-25-028403
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health adopts 1-year rights plan after receiving acquisition interest
----------------------------------------------------------------------------

- Board adopted limited-duration rights plan on Feb 26, 2025; expires Feb 26, 2026.
- Rights trigger at 20% beneficial ownership of voting stock; holders can buy shares at $4.50 for twice the market value.
- Jaguar received indication of interest to acquire the company; plan aims to discourage open-market accumulation without a premium.
- First proof-of-concept IIT results for crofelemer in SBS-IF and MVID expected Q2 2025; FDA meeting on breast cancer subgroup results also Q2.
- Record date for rights dividend is March 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025028403/0000950170-25-028403-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025028403/jagx-20250226.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-028403

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer